BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7422429)

  • 1. Nephropathy in the Wiskott-Aldrich syndrome.
    Spitler LE; Wray BB; Mogerman S; Miller JJ; O'Reilly RJ; Lagios M
    Pediatrics; 1980 Sep; 66(3):391-8. PubMed ID: 7422429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
    Guss RB; McCulley JP
    Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
    Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
    Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
    J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An autopsy case of Wiskott-Aldrich syndrome in a 21-year-old male with renal failure (author's transl)].
    Tanaka S; Kita K; Yasue H; Ito T; Omine M; Horiuchi T
    Rinsho Ketsueki; 1978 Dec; 19(12):1665-71. PubMed ID: 739620
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfer factor therapy: evidence for nonspecificity.
    Ballow M; Dupont B; Hansen JA; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patients.
    Spitler LE
    Am J Med; 1979 Jul; 67(1):59-66. PubMed ID: 463917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism.
    Blaese RM; Strober W; Levy AL; Waldmann TA
    J Clin Invest; 1971 Nov; 50(11):2331-8. PubMed ID: 5096517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oldest survivor with Wiskott-Aldrich syndrome.
    Pritikin RI; Fudenberg HH
    Metab Pediatr Ophthalmol; 1980; 4(3):169-71. PubMed ID: 7453283
    [No Abstract]   [Full Text] [Related]  

  • 11. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor].
    Endre L; Nékám K; Osváth P; Nagy M; Károly U; Uhl K
    Orv Hetil; 1979 Sep; 120(39):2361-6. PubMed ID: 392396
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized trial of transfer factor treatment of human warts.
    Stevens DA; Ferrington RA; Merigan TC; Marinkovich VA
    Clin Exp Immunol; 1975 Sep; 21(3):520-4. PubMed ID: 1106927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute immune complex mediated glomerulonephritis in a Chinese girl with Wiskott-Aldrich syndrome variant.
    Lin CY; Hsu HC
    Ann Allergy; 1984 Jul; 53(1):74-8. PubMed ID: 6377982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.
    Lum LG; Tubergen DG; Corash L; Blaese RM
    N Engl J Med; 1980 Apr; 302(16):892-6. PubMed ID: 6767187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated donor BMT for Wiskott-Aldrich syndrome.
    Lenarsky C; Weinberg K; Kohn DB; Parkman R
    Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA glomerulonephritis in Wiskott-Aldrich syndrome.
    DeSanto NG; Sessa A; Capodicasa G; Meroni M; Capasso G; Esposito L; Ferrara M; Torri Tarelli L; Annunziata S; Giordano C
    Child Nephrol Urol; 1988-1989; 9(1-2):118-20. PubMed ID: 3251617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive varicella in three patients with Wiskott-Aldrich syndrome: treatment with adenine arabinoside.
    Wade NA; Lepow ML; Veazey J; Meuwissen HJ
    Pediatrics; 1985 Apr; 75(4):672-5. PubMed ID: 3982899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary experience with the treatment of a case of Wiskott-Aldrich syndrome with transfer factor].
    Balsamo V; Brai M; Mogavero S; Tolone G; La Grutta A
    Minerva Pediatr; 1977 Mar; 29(10):651-5. PubMed ID: 875932
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.